MOMENTA PHARMACEUTICALS INC Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Cash Flows from Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization of property and equipment
Impairment of equipment
Share-based compensation expense
Amortization of discount (premium) on investments
Amortization of intangibles
Loss (gain) on disposal of assets
Changes in operating assets and liabilities:
Collaboration receivable
Unbilled revenue
Prepaid expenses and other current assets
Restricted cash
Other long-term assets
Accounts payable
Accrued expenses
Accrued restructuring
Collaboration liabilities
Deferred revenue
Lease incentive
Other current liabilities
Other long-term liabilities

Net cash (used in) provided by operating activities
Net cash used in operating activities
Cash Flows from Investing Activities:
Purchases of property and equipment
Proceeds from disposal of equipment
Purchases of marketable securities
Proceeds from maturities of marketable securities
Net cash provided by (used in) investing activities
Cash Flows from Financing Activities:
Proceeds from public offering of common stock, net of issuance costs
Net proceeds from issuance of common stock
Proceeds from issuance of common stock under stock plans
Repurchase of common stock pursuant to share surrender
Net cash provided by financing activities
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents
Net cash provided by financing activities
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
Non-Cash Activities:
Common shares issued to Parivid to settle milestone payment
Purchases of property and equipment included in accounts payable and accrued expenses
Deferred financing fees in accounts payable and accrued expenses
Receivable due from stock option exercises
Impact from adoption of ASUs
Accounting Standards Update 2016-09
Accounting Standards Update 2014-09
Total impact from adoption of ASUs

Comments